Data / Form D filings / March Biosciences, Inc.
March Biosciences, Inc.: Form D filings
March Biosciences, Inc., a biotechnology company in Houston, TX, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on October 22, 2024, reports $22.1 million sold of a $22.1 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7255 Helix Park, Suite 300, Houston, TX, 77030
- Phone
- (713) 898-0838
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1965802
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2024 | New notice | $22,140,942 | $22,140,942 | 22 | Oct 7, 2024 | sec.gov | |
| Sep 12, 2023 | New notice | $8,870 | $8,870 | 1 | Sep 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Luby | Director | |
| Peter Olagunju | Director | |
| Joseph Petrosino | Director | |
| Sarah Hein | Director, Executive Officer | |
| Maksim Mamonkin | Director, Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Oct 21, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what March Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.